Clinical characteristics and outcomes in participants with screen-detected clinical stage I lung cancer in the Yorkshire lung screening trial: A comparison of surgery versus stereotactic ablative radiotherapy
Open Access
- 3 November 2025
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 210, 108816
Abstract
No abstract availableKeywords
Funding Information
- Yorkshire Cancer Research
This publication has 27 references indexed in Scilit:
- Brief Report: Evaluating Early Stage Lung Cancer Survival Patterns in Patients at the Upper Age Limit for Lung Cancer ScreeningJournal of Thoracic Oncology, 2024
- Prospective Evaluation of Lung Cancer Screening Eligibility Criteria and Lung Cancer Detection in the Yorkshire Lung Screening TrialJournal of Thoracic Oncology, 2024
- Factors influencing patient satisfaction after treatments for early-stage non-small cell lung cancerJournal of Cancer Research and Clinical Oncology, 2021
- Screening for Lung CancerJAMA, 2021
- Overdiagnosis in lung cancer screening: Estimates from the German Lung Cancer Screening Intervention TrialInternational Journal of Cancer, 2020
- Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening TrialJournal of Thoracic Oncology, 2019
- Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR CohortClinical Oncology, 2016
- Survival Outcome After Stereotactic Body Radiation Therapy and Surgery for Stage I Non-Small Cell Lung Cancer: A Meta-AnalysisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Stereotactic body radiation therapy versus surgical resection for stage I non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Cancer Screening in Elderly PatientsJAMA, 2001